| P2093 | author name string | Jan U Becker | |
| P2860 | cites work | Seroepidemiology of human polyomaviruses | Q21089620 |
| | Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome | Q24337607 |
| | De novo glomerular diseases after renal transplantation | Q27005877 |
| | Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome | Q33375728 |
| | Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy | Q33632316 |
| | Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis | Q33872298 |
| | Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice | Q33974535 |
| | Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. | Q34260097 |
| | International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 |
| | Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring | Q34775333 |
| | Pathologic classification of focal segmental glomerulosclerosis | Q35110846 |
| | Adenovirus pyelonephritis in a pediatric renal transplant patient | Q35123613 |
| | A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease | Q35132279 |
| | Isolated endarteritis and kidney transplant survival: a multicenter collaborative study | Q35550570 |
| | Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts | Q35790552 |
| | Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection | Q35922715 |
| | Pediatric renal transplantation: comparative study with renal transplantation in the adult population | Q36267249 |
| | The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection | Q68704052 |
| | Morphology and Pathogenesis of Glomerulopathy in Cadaver Kidney Allografts Treated with Antilymphocyte Globulin | Q69253240 |
| | Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema | Q71157326 |
| | Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin | Q71674294 |
| | Early protocol renal allograft biopsies and graft outcome | Q71974528 |
| | Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study | Q73028648 |
| | An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome | Q73100006 |
| | Occurrence of Urinary Tract Infection in Patients with Renal Allograft Biopsies Showing Neutrophilic Tubulitis | Q73262760 |
| | C4d deposition in the glomeruli and peritubular capillaries associated with transplant glomerulopathy | Q73685894 |
| | Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation | Q79369493 |
| | Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies | Q81423059 |
| | Chronic transplant glomerulopathy: need for further assessment | Q81454233 |
| | Safety and adequacy of renal transplant protocol biopsies | Q81923103 |
| | Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies | Q82715812 |
| | IgA nephropathy recurs early in the graft when assessed by protocol biopsy | Q82945306 |
| | Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients | Q83828789 |
| | Transplant glomerulopathy: morphology, associations and mechanism | Q84203169 |
| | Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study | Q84398837 |
| | Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy | Q84870337 |
| | Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies | Q85903520 |
| | Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts | Q86069960 |
| | Fidelity and evolution of recurrent FSGS in renal allografts. | Q36949204 |
| | C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 |
| | Abatacept in B7-1-positive proteinuric kidney disease | Q37633142 |
| | Clinical findings, pathology, and outcomes of C3GN after kidney transplantation | Q37733586 |
| | C3 glomerulopathy: a new classification | Q37770399 |
| | A position paper on standardizing the nonneoplastic kidney biopsy report. | Q38026231 |
| | Do protocol transplant biopsies improve kidney transplant outcomes? | Q38050004 |
| | Antibody-mediated vascular rejection of kidney allografts: a population-based study | Q38062614 |
| | Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression | Q41830265 |
| | Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. | Q42111937 |
| | Donor origin of BKV replication after kidney transplantation | Q42247712 |
| | Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study | Q42279035 |
| | A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies | Q42846833 |
| | Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 |
| | Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts | Q43927416 |
| | Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane | Q44015821 |
| | Subclinical rejection in tacrolimus-treated renal transplant recipients | Q44072914 |
| | Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts | Q44180277 |
| | Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. | Q44260404 |
| | Impact of Banff borderline acute rejection among renal allograft recipients | Q44561646 |
| | Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 |
| | Predominance of TH2 cells and plasma cells in polyoma virus nephropathy: a role for humoral immunity? | Q45359046 |
| | Identifying specific causes of kidney allograft loss. | Q45810388 |
| | Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk | Q46881113 |
| | Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence, and electron microscopic study | Q47764319 |
| | Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates | Q48901557 |
| | A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. | Q51432032 |
| | The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes. | Q52876472 |
| | Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. | Q52899504 |
| | Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. | Q52939931 |
| | Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance. | Q53097837 |
| | Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies. | Q53141154 |
| | Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy. | Q53244183 |
| | Comparison of C4d immunostaining methods in renal allograft biopsies. | Q53564483 |
| | Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. | Q54155485 |
| | Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 |
| | Defining the canonical form of T-cell-mediated rejection in human kidney transplants. | Q54442988 |
| | Thrombotic Microangiopathy After Kidney Transplantation | Q57702140 |
| | Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients | Q58004250 |
| | The Banff 97 working classification of renal allograft pathology | Q59314413 |
| | A specific glomerular lesion of the graft: allograft glomerulopathy | Q59619388 |
| | Immunephenotype of Glomerular and Interstitial Infiltrating Cells in Protocol Renal Allograft Biopsies and Histological Diagnosis | Q62619829 |
| | Ultrastructure of transplant glomerulopathy | Q67234807 |
| | Transplantation arteriopathy | Q67484628 |
| | Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 |
| P433 | issue | 3 | |
| P304 | page(s) | 425-437 | |
| P577 | publication date | 2016-05-24 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Current status of pediatric renal transplant pathology | |
| P478 | volume | 32 | |